等待開盤 03-26 09:30:00 美东时间
+0.090
+2.18%
今日重点评级关注:韦德布什:维持Black Diamond Therapeutic"跑赢大市"评级,目标价从13美元升至14美元;花旗:维持Olema Pharmaceuticals"买入"评级,目标价从60美元升至62美元
03-18 10:48
HC Wainwright & Co. analyst Heiko F. Ihle maintains Atlas Lithium (NASDAQ:ATLX) with a Buy and raises the price target from $12 to $12.5.
03-17 19:29
(来源:矿业俱乐部) 大宗商品超级新周期已然开启,为深度解码全球矿业新周期下的结构性机遇与挑战,赋能企业全球矿业发展新逻辑以及"双碳"战略与...
03-17 17:00
Shares of lithium-related companies are trading lower amid a possible selloff. ...
02-27 02:27
Atlas Lithium Corporation (NASDAQ:ATLX) ("Atlas Lithium" or "Company"), a leading lithium exploration and development company, is pleased to announce that its subsidiary, Atlas Critical Minerals Corporation ("Atlas
01-14 21:39
As previously disclosed, Atlas Lithium Corporation (the "Company") entered into that certain At The Market Offering Agreement, dated November 22, 2024 (the "Agreement") with H.C. Wainwright & Co., LLC, as sales agent
2025-12-13 05:38
Roger Noriega, a Director of Atlas Lithium Corporation, reported a disposal of common shares of Atlas Lithium Corporation, according to a recent SEC Form 4 filing. The full filing can be accessed thro...
2025-12-03 10:01
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
HC Wainwright & Co. analyst Heiko F. Ihle maintains Atlas Lithium (NASDAQ:ATLX) with a Buy and lowers the price target from $18 to $12.
2025-11-17 19:44
Atlas Lithium (NASDAQ:ATLX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.64) by 45.31 percent. This is a 41.67 percent increase over losses of $(0.60) per share from the
2025-11-14 06:17